Skip to: Content
Skip to: Site Navigation
Skip to: Search

September 5, 2008 11:35:58 AM CDT

Learn about Newser Points »

« Back to the grid | Next story »

Schizophrenia Drug Offers New Hope

Posted Sep 3, 07 3:58 AM CDT in US,  Business,  Science & Health 

(Newser) – The first human trial of a new medication to treat schizophrenia that works fundamentally differently from its predecessors has shown promising results, according to this month's Nature Medicine. The drug targets glutamate rather than dopamine, as do other drugs. Scientists have long known glutamate is involved in schizophrenia.

The new drug alleviates symptom with few of the side effects of current anti-psychotics, such as tremors and weight gain. Drug manufacturer Eli Lilly plans to determine the optimal dosage for the medication before moving on to the final stage of testing and filing for FDA approval. Schizophrenia, which can involve delusions and hallucinations, affects 1% of the population, about the same as diabetes.

Source BBC

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • Psych Drugs Drove Kid Crazy

    May 18, 07 9:44 PM CDT
    Psych Drugs Drove Kid Crazy The careless prescription of anti-psychotic drugs, often by psychiatrists who draw pay checks from the companies who make them, has drawn attention in the New York Times recently. Now Ann Bauer, writing in Salon, draws an intimate portrait of the effects of such carelessness on one autistic teenager, who turned from shy chess nerd to psychotic bruiser. More »

  • Use of Antipsychotics For Kids Soars

    May 10, 07 10:23 AM CDT
    Use of Antipsychotics For Kids Soars The Times tackles the growing use of antipsychotic drugs in children, contentious because the drugs are risky and have no approved use for minors. But the trend is also questionable because it coincides with increasing payments to psychiatrists by the companies that market the drugs. In Minnesota, these payments rose sixfold from 2000 to 2005. More »

  • Alzheimer's Patients Dying In Prescription Scandal

    Mar 30, 07 10:13 AM CDT
    Alzheimer's Patients Dying In Prescription Scandal Sedatives commonly prescribed to Alzheimer's and dementia patients are leading to their premature death, new research reported in the Guardian concludes.  The drugs, called neuroleptics, combat the diseases' more alarming symptoms, including agitation and hallucinations. Their widespread off-label use in the U.K.—where they're licensed only for schitzophrenia—is being called a scandal. More »

A women leaves the Eli Lilly and Company campus in an Indianapolis file photo from April 18, 2006.   (Associated Press)
Medicine cabinet   (KRT Photos)
Sue Voyles, daughter, Elena Ken Voyles and son, Ethan Voyles of Canton, Michigan. Like most families, the Voyles will deal with issues of health care in America.   (KRT Photos)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 1)

Tags

medicine  • schizophrenia  • antipsychotic drugs  • Eli Lilly  • dopamine


Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular


Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »